Question follow-through · 107545
Prostate Cancer: Abiraterone
To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the Northern Ireland (a) Department of Health and (b) Health and Social Care Board on levels of accessibility to abiraterone for non-metastatic prost
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 21 Jan 2026
- Target answer date
- 26 Jan 2026
- Answer
- 28 Jan 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Public Expenditure: Northern Ireland · 3 Feb 2026
- Cancer: Children · 3 Feb 2026
- Allergies: Medical Treatments · 20 May 2026
- Medical Treatments: Standards · 2 Jul 2026
- Cancer: Children · 16 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
21 Jan 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the Northern Ireland (a) Department of Health and (b) Health and Social Care Board on levels of accessibility to abiraterone for non-metastatic prost
26 Jan 2026
Target answer date
Date supplied by the official written-questions record.
28 Jan 2026
Answer published
There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Public Expenditure: Northern Ireland
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what Barnett consequentials arise for Northern Ireland as a result of the £10 million per year funding announced to cover travel costs for children and young people with cancer in England.
Cancer: Children
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the Northern Ireland Department of Health and the Northern Ireland Executive to ensure that families of children and young people with cancer in Northern Ireland ca
Allergies: Medical Treatments
20 May 2026 · To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the introduction of EURneffy for use in the emergency treatment of serious allergies.
Medical Treatments: Standards
2 Jul 2026 · To ask the Secretary of State for Health and Social Care, when the EQ-5D-5L quality of life value set will be adopted in NICE technology appraisals.
Cancer: Children
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether families in Northern Ireland are eligible for the £10 million cancer travel fund for children.
Cancer: Children
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, how the £10 million England fund to cover the travel costs of children with cancer was calculated; and what assessment he has made of the potential merits of extending the fund across the UK.